-   directed: true
    comment: Trilostane was withdrawn from the United States market in April 1994 | MESH:D000308 refers to higher term Adrenocortical Hyperfunction that includes Hypercortisolism
    graph:
        drug: Trilostane
        drugbank: DB:DB01108
        drug_mesh: MESH:C009954
        disease: Hypercortisolism
        disease_mesh: MESH:D000308
    links:
    -   key: decreases activity of
        source: MESH:C009954
        target: InterPro:IPR002225
    -   key: negatively regulates
        source: InterPro:IPR002225
        target: REACT:R-HSA-196071
    -   key: decreases abundance of
        source: REACT:R-HSA-196071
        target: MESH:D013256
    -   key: negatively regulates
        source: InterPro:IPR002225
        target: REACT:R-HSA-193993
    -   key: decreases abundance of
        source: REACT:R-HSA-193993
        target: MESH:D013256
    -   key: negatively regulates
        source: InterPro:IPR002225
        target: REACT:R-HSA-194002
    -   key: decreases abundance of
        source: REACT:R-HSA-194002
        target: MESH:D013256
    -   key: manifestation of
        source: MESH:D013256
        target: MESH:D000308
    multigraph: true
    nodes:
    -   id: MESH:C009954
        label: Drug
        name: Trilostane
    -   id: InterPro:IPR002225
        label: GeneFamily
        name: 3-beta-hydroxysteroid dehydrogenase/delta 5,4 ketosteroid isomerase
    -   id: REACT:R-HSA-196071
        label: Pathway
        name: Metabolism of steroid hormones
    -   id: REACT:R-HSA-193993
        label: Pathway
        name: Mineralocorticoid biosynthesis
    -   id: REACT:R-HSA-194002
        label: Pathway
        name: Glucocorticoid biosynthesis
    -   id: MESH:D013256
        label: ChemicalSubstance
        name: Steroids
    -   id: MESH:D000308
        label: Disease
        name: Hypercortisolism
    reference: https://go.drugbank.com/drugs/DB01108#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Trilostane
-   directed: true
    graph:
        drug: Calcium Phosphate
        drugbank: DB:DB11348
        drug_mesh: MESH:C020243
        disease: Osteoporosis
        disease_mesh: MESH:D010024
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: increases activity of
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: decreases secretion of
        source: InterPro:IPR000276
        target: UniProt:P01270
    -   key: decreases abundance of
        source: UniProt:P01270
        target: MESH:D002112       
    -   key: decreases expression of
        source: MESH:D002112
        target: InterPro:IPR008250
    -   key: negatively regulates
        source: InterPro:IPR008250
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0000945
    -   key: negatively regulates
        source: UBERON:0000945
        target: GO:0045453
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: negatively regulates
        source: UniProt:Q9H1D0
        target: GO:0006816
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9NQA5
    -   key: negatively regulates
        source: UniProt:Q9NQA5
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0002113
    -   key: negatively regulates
        source: UBERON:0002113
        target: GO:0045453
    -   key: positively regulates
        source: UniProt:P01270
        target: UniProt:P06881
    -   key: negatively regulates
        source: UniProt:P06881
        target: GO:0045453
    -   key: negatively regulates
        source: UniProt:P01270
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: CL:0000137
    -   key: negatively regulates
        source: CL:0000137
        target: GO:0045453
    -   key: positively regulates
        source: GO:0045453
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: manifestation of
        source: GO:0055074
        target: MESH:D010024
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: Calcium Phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor
    -   id: UniProt:P01270
        label: Protein
        name: Parathyroid hormone
    -   id: GO:0006816
        label: BiologicalProcess
        name: Calcium ion transport
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphate
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcidiol
    -   id: InterPro:IPR008250
        label: GeneFamily
        name: Calcium dependent ATPases
    -   id: UBERON:0000945
        label: GrossAnatomicalStructure
        name: Gut
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6 (TRPV6)   
    -   id: UniProt:Q9NQA5
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 5 (TRPV5) 
    -   id: UBERON:0002113
        label: GrossAnatomicalStructure
        name: Kidney
    -   id: UniProt:P06881
        label: Protein
        name: Calcitonin      
    -   id: CL:0000137
        label: Cell
        name: Osteocyte
    -   id: GO:0045453
        label: BiologicalProcess
        name: Bone resorption
    -   id: GO:0055074
        label: BiologicalProcess
        name: Calcium ion homeostasis
    -   id: MESH:D010024
        label: Disease
        name: Osteoporosis
    reference: https://go.drugbank.com/drugs/DB11348#mechanismofaction
-   directed: true
    graph:
        drug: Calcium Phosphate
        drugbank: DB:DB11348
        drug_mesh: MESH:C020243
        disease: Hypocalcemia
        disease_mesh: MESH:D006996
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: increases activity of
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: decreases secretion of
        source: InterPro:IPR000276
        target: UniProt:P01270
    -   key: decreases abundance of
        source: UniProt:P01270
        target: MESH:D002112       
    -   key: decreases expression of
        source: MESH:D002112
        target: InterPro:IPR008250
    -   key: negatively regulates
        source: InterPro:IPR008250
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0000945
    -   key: negatively regulates
        source: UBERON:0000945
        target: GO:0045453
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: negatively regulates
        source: UniProt:Q9H1D0
        target: GO:0006816
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9NQA5
    -   key: negatively regulates
        source: UniProt:Q9NQA5
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0002113
    -   key: negatively regulates
        source: UBERON:0002113
        target: GO:0045453
    -   key: positively regulates
        source: UniProt:P01270
        target: UniProt:P06881
    -   key: negatively regulates
        source: UniProt:P06881
        target: GO:0045453
    -   key: negatively regulates
        source: UniProt:P01270
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: CL:0000137
    -   key: negatively regulates
        source: CL:0000137
        target: GO:0045453
    -   key: positively regulates
        source: GO:0045453
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: manifestation of
        source: GO:0055074
        target: MESH:D006996
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: Calcium Phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor
    -   id: UniProt:P01270
        label: Protein
        name: Parathyroid hormone
    -   id: GO:0006816
        label: BiologicalProcess
        name: Calcium ion transport
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphate
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcidiol
    -   id: InterPro:IPR008250
        label: GeneFamily
        name: Calcium dependent ATPases
    -   id: UBERON:0000945
        label: GrossAnatomicalStructure
        name: Gut
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6 (TRPV6)   
    -   id: UniProt:Q9NQA5
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 5 (TRPV5) 
    -   id: UBERON:0002113
        label: GrossAnatomicalStructure
        name: Kidney
    -   id: UniProt:P06881
        label: Protein
        name: Calcitonin      
    -   id: CL:0000137
        label: Cell
        name: Osteocyte
    -   id: GO:0045453
        label: BiologicalProcess
        name: Bone resorption
    -   id: GO:0055074
        label: BiologicalProcess
        name: Calcium ion homeostasis
    -   id: MESH:D006996
        label: Disease
        name: Hypocalcemia
    reference: https://go.drugbank.com/drugs/DB11348#mechanismofaction
-   directed: true
    graph:
        drug: Calcium Phosphate
        drugbank: DB:DB11348
        drug_mesh: MESH:C020243
        disease: Postmenopausal osteoporosis
        disease_mesh: MESH:D015663
    links:
    -   key: derives into
        source: MESH:C020243
        target: MESH:D002118
    -   key: derives into
        source: MESH:C020243
        target: MESH:D010710
    -   key: increases activity of
        source: MESH:D002118
        target: InterPro:IPR000276
    -   key: decreases secretion of
        source: InterPro:IPR000276
        target: UniProt:P01270
    -   key: decreases abundance of
        source: UniProt:P01270
        target: MESH:D002112       
    -   key: decreases expression of
        source: MESH:D002112
        target: InterPro:IPR008250
    -   key: negatively regulates
        source: InterPro:IPR008250
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0000945
    -   key: negatively regulates
        source: UBERON:0000945
        target: GO:0045453
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9H1D0
    -   key: negatively regulates
        source: UniProt:Q9H1D0
        target: GO:0006816
    -   key: decreases expression of
        source: MESH:D002112
        target: UniProt:Q9NQA5
    -   key: negatively regulates
        source: UniProt:Q9NQA5
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: UBERON:0002113
    -   key: negatively regulates
        source: UBERON:0002113
        target: GO:0045453
    -   key: positively regulates
        source: UniProt:P01270
        target: UniProt:P06881
    -   key: negatively regulates
        source: UniProt:P06881
        target: GO:0045453
    -   key: negatively regulates
        source: UniProt:P01270
        target: GO:0006816
    -   key: located in
        source: GO:0006816
        target: CL:0000137
    -   key: negatively regulates
        source: CL:0000137
        target: GO:0045453
    -   key: positively regulates
        source: GO:0045453
        target: GO:0055074
    -   key: positively regulates
        source: MESH:D010710
        target: GO:0055074
    -   key: manifestation of
        source: GO:0055074
        target: MESH:D015663
    multigraph: true
    nodes:
    -   id: MESH:C020243
        label: Drug
        name: Calcium Phosphate
    -   id: MESH:D002118
        label: ChemicalSubstance
        name: Calcium
    -   id: InterPro:IPR000276
        label: GeneFamily
        name: G protein-coupled receptor
    -   id: UniProt:P01270
        label: Protein
        name: Parathyroid hormone
    -   id: GO:0006816
        label: BiologicalProcess
        name: Calcium ion transport
    -   id: MESH:D010710
        label: ChemicalSubstance
        name: Phosphate
    -   id: MESH:D002112
        label: ChemicalSubstance
        name: Calcidiol
    -   id: InterPro:IPR008250
        label: GeneFamily
        name: Calcium dependent ATPases
    -   id: UBERON:0000945
        label: GrossAnatomicalStructure
        name: Gut
    -   id: UniProt:Q9H1D0
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 6 (TRPV6)   
    -   id: UniProt:Q9NQA5
        label: Protein
        name: Transient receptor potential cation channel subfamily V member 5 (TRPV5) 
    -   id: UBERON:0002113
        label: GrossAnatomicalStructure
        name: Kidney
    -   id: UniProt:P06881
        label: Protein
        name: Calcitonin      
    -   id: CL:0000137
        label: Cell
        name: Osteocyte
    -   id: GO:0045453
        label: BiologicalProcess
        name: Bone resorption
    -   id: GO:0055074
        label: BiologicalProcess
        name: Calcium ion homeostasis
    -   id: MESH:D015663
        label: Disease
        name: Postmenopausal osteoporosis
    reference: https://go.drugbank.com/drugs/DB11348#mechanismofaction
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Wilson's disease
        disease_mesh: MESH:D006527
    links:
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D003300
    -   key: positively regulates
        source: MESH:D003300
        target: GO:0055070
    -   key: manifestation of
        source: GO:0055070
        target: MESH:D006527
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: MESH:D003300
        label: ChemicalSubstance
        name: Copper
    -   id: GO:0055070
        label: BiologicalProcess
        name: Copper ion homeostasis
    -   id: MESH:D006527
        label: Disease
        name: Wilson's disease
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D054856
    -   key: decreases activity of
        source: MESH:D054856
        target: InterPro:IPR003545
    -   key: negatively regulates
        source: InterPro:IPR003545
        target: GO:0016049
    -   key: located in
        source: GO:0016049
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: MESH:D054856
        label: ChemicalSubstance
        name: G-quadruplex
    -   id: InterPro:IPR003545
        label: GeneFamily
        name: Telomerase
    -   id: GO:0016049
        label: BiologicalProcess
        name: Cell growth
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D003300
    -   key: decreases activity of
        source: MESH:D003300
        target: InterPro:IPR000072
    -   key: negatively regulates
        source: InterPro:IPR000072
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P05230
    -   key: negatively regulates
        source: UniProt:P05230
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: InterPro:IPR000975
    -   key: negatively regulates
        source: InterPro:IPR000975
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: InterPro:PR003573
    -   key: negatively regulates
        source: InterPro:PR003573
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P10145
    -   key: negatively regulates
        source: UniProt:P10145
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P19838
    -   key: negatively regulates
        source: UniProt:P19838
        target: GO:0001525
    -   key: decreases activity of
        source: MESH:D003300
        target: UniProt:P00441
    -   key: negatively regulates
        source: UniProt:P00441
        target: GO:0001525
    -   key: located in
        source: GO:0001525
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: MESH:D003300
        label: ChemicalSubstance
        name: Copper
    -   id: InterPro:IPR000072
        label: GeneFamily
        name: Vascular endothelial growth factor-1
    -   id: UniProt:P00441
        label: Protein
        name: Superoxide dismutase 1
    -   id: UniProt:P19838
        label: Protein
        name: Nuclear factor kappa-light-chain-enhancer of activated B cells
    -   id: UniProt:P10145
        label: Protein
        name: Interleukin 8
    -   id: InterPro:PR003573
        label: GeneFamily
        name: Interleukin 6
    -   id: InterPro:IPR000975
        label: GeneFamily
        name: Interleukin 1
    -   id: UniProt:P05230
        label: Protein
        name: Fibroblast growth factor-1
    -   id: GO:0001525
        label: BiologicalProcess
        name: Angiogenesis
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Trientine is the salt form of Triethylenetetramine (DB06824)
    graph:
        drug: Trientine
        drugbank: DB:DB06824
        drug_mesh: MESH:D014266
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: negatively regulates
        source: MESH:D014266
        target: REACT:R-HSA-6802957
    -   key: causes
        source: REACT:R-HSA-6802957
        target: GO:0012501
    -   key: molecularly interacts with
        source: MESH:D014266
        target: MESH:D003300
    -   key: increases abundance of
        source: MESH:D003300
        target: MESH:D000975
    -   key: causes
        source: MESH:D000975
        target: GO:0012501       
    -   key: located in
        source: GO:0012501
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: MESH:D014266
        label: Drug
        name: Trientine
    -   id: REACT:R-HSA-6802957
        label: Pathway
        name: Oncogenic MAPK signaling
    -   id: MESH:D003300
        label: ChemicalSubstance
        name: Copper
    -   id: MESH:D000975
        label: ChemicalSubstance
        name: Antioxidants
    -   id: GO:0012501
        label: BiologicalProcess
        name: Apoptosis
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06824#mechanismofaction DOI:10.1158/1535-7163.MCT-10-0523 https://pubchem.ncbi.nlm.nih.gov/compound/Trientine-hydrochloride#section=Pharmacology-and-Biochemistry
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Nocardiosis
        disease_mesh: MESH:D009617
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:U5EHR3
    -   key: decreases abundance of
        source: UniProt:U5EHR3
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:1824
    -   key: causes
        source: NCBITaxon:1824
        target: MESH:D009617
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:U5EHR3
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:1824
        label: OrganismTaxon
        name: Nocardia asteroides 
    -   id: MESH:D009617
        label: Disease
        name: Nocardiosis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Shigellosis
        disease_mesh: MESH:D004405
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:A0A3C0GZY2
    -   key: decreases abundance of
        source: UniProt:A0A3C0GZY2
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:543
    -   key: causes
        source: NCBITaxon:543
        target: MESH:D004405
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:A0A3C0GZY2
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:543
        label: OrganismTaxon
        name: Enterobacteriaceae
    -   id: MESH:D004405
        label: Disease
        name: Shigellosis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Toxoplasmosis
        disease_mesh: MESH:D014123
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:Q4U207
    -   key: decreases abundance of
        source: UniProt:Q4U207
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:5811
    -   key: causes
        source: NCBITaxon:5811
        target: MESH:D014123
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:Q4U207
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:5811
        label: OrganismTaxon
        name: Toxoplasma gondii
    -   id: MESH:D014123
        label: Disease
        name: Toxoplasmosis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    comment: Sulfamethoxazole is given in combination with trimethoprim
    graph:
        drug: Sulfamethoxazole
        drugbank: DB:DB01015
        drug_mesh: MESH:D013420
        disease: Chlamydial conjunctivitis
        disease_mesh: MESH:D003235
    links:
    -   key: decreases activity of
        source: MESH:D013420
        target: UniProt:A0A655MZZ2
    -   key: decreases abundance of
        source: UniProt:A0A655MZZ2
        target: MESH:D005492
    -   key: prevents
        source: MESH:D005492
        target: GO:0071897
    -   key: in taxon
        source: GO:0071897
        target: NCBITaxon:813
    -   key: causes
        source: NCBITaxon:813
        target: MESH:D003235
    multigraph: true
    nodes:
    -   id: MESH:D013420
        label: Drug
        name: Sulfamethoxazole
    -   id: UniProt:A0A655MZZ2
        label: Protein
        name: Dihydropteroate synthase
    -   id: MESH:D005492
        label: ChemicalSubstance
        name: Folic acid
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA synthesis
    -   id: NCBITaxon:813
        label: OrganismTaxon
        name: Chlamydia trachomatis
    -   id: MESH:D003235
        label: Disease
        name: Chlamydial conjunctivitis
    reference: https://go.drugbank.com/drugs/DB01015#mechanismofaction https://en.wikipedia.org/wiki/Sulfamethoxazole
-   directed: true
    graph:
        drug: Penciclovir
        drugbank: DB:DB00299
        drug_mesh: MESH:C053539
        disease: Herpes labialis
        disease_mesh: MESH:D006560
    links:
    -   key: increases abundance of
        source: MESH:C053539
        target: MESH:C092310
    -   key: decreases molecular interaction
        source: MESH:C092310
        target: MESH:C029603
    -   key: decreases activity of
        source: MESH:C029603
        target: UniProt:Q99FY1
    -   key: prevents
        source: UniProt:Q99FY1
        target: GO:0019079
    -   key: in taxon
        source: GO:0019079
        target: NCBITaxon:10292
    -   key: causes
        source: NCBITaxon:10292
        target: MESH:D006560
    multigraph: true
    nodes:
    -   id: MESH:C053539
        label: Drug
        name: Penciclovir
    -   id: MESH:C092310
        label: ChemicalSubstance
        name: Penciclovir triphosphate
    -   id: MESH:C029603
        label: ChemicalSubstance
        name: Deoxyguanosine triphosphate 
    -   id: UniProt:Q99FY1
        label: Protein
        name: Viral DNA polymerase
    -   id: GO:0019079
        label: BiologicalProcess
        name: Viral replication
    -   id: NCBITaxon:10292
        label: OrganismTaxon
        name: Herpesviridae
    -   id: MESH:D006560
        label: Disease
        name: Herpes labialis
    reference: https://go.drugbank.com/drugs/DB00299#mechanismofaction
-   directed: true
    graph:
        drug: Axitinib
        drugbank: DB:DB06626
        drug_mesh: NULL
        disease: Renal cell carcinoma
        disease_mesh: MESH:D002292
    links:
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P17948
    -   key: negatively regulates
        source: UniProt:P17948
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P35968
    -   key: negatively regulates
        source: UniProt:P35968
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P35916
    -   key: negatively regulates
        source: UniProt:P35916
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: InterPro:IPR006782
    -   key: negatively regulates
        source: InterPro:IPR006782
        target: GO:0001525
    -   key: decreases activity of
        source: DB:DB06626
        target: UniProt:P10721
    -   key: negatively regulates
        source: UniProt:P10721
        target: GO:0001525
    -   key: located in
        source: GO:0001525
        target: CL:0001063 
    -   key: causes
        source: CL:0001063 
        target: MESH:D002292
    multigraph: true
    nodes:
    -   id: DB:DB06626
        label: Drug
        name: Axitinib
    -   id: UniProt:P17948
        label: Protein
        name: Vascular endothelial growth factor receptor 1
    -   id: UniProt:P35968
        label: Protein
        name: Vascular endothelial growth factor receptor 2
    -   id: UniProt:P35916
        label: Protein
        name: Vascular endothelial growth factor receptor 3
    -   id: InterPro:IPR006782
        label: GeneFamily
        name: Platelet-derived growth factor receptor
    -   id: UniProt:P10721
        label: Protein
        name: c-Kit
    -   id: GO:0001525
        label: BiologicalProcess
        name: Angiogenesis
    -   id: CL:0001063 
        label: Cell
        name: Tumor cell
    -   id: MESH:D002292
        label: Disease
        name: Renal cell carcinoma
    reference: https://go.drugbank.com/drugs/DB06626#mechanismofaction https://en.wikipedia.org/wiki/Axitinib
